학술논문

Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial
Document Type
Article
Source
In: Arthritis and Rheumatology. (Arthritis and Rheumatology, March 2021, 73(3):530-541)
Subject
Language
English
ISSN
23265205
23265191